Centene sank -1.4% this afternoon, compared to the S&P 500's day change of 0.0%. Today's losers may turn out to be tomorrow's winners, so be sure to check the stock's fundamentals before making an investment decision:
-
Centene has logged a -8.7% 52 week change, compared to 22.9% for the S&P 500
-
CNC has an average analyst rating of buy and is -14.16% away from its mean target price of $85.6 per share
-
Its trailing earnings per share (EPS) is $4.51, which brings its trailing Price to Earnings (P/E) ratio to 16.3. The Health Care sector's average P/E ratio is 30.21
-
The company's forward earnings per share (EPS) is $6.8 and its forward P/E ratio is 10.8
-
The company has a Price to Book (P/B) ratio of 1.55 in contrast to the Health Care sector's average P/B ratio is 4.08
-
CNC has reported YOY quarterly earnings growth of -31.6% and gross profit margins of 0.2%
-
The company's free cash flow for the last fiscal year was $5.45 Billion and the average free cash flow growth rate is 52.2%
-
Centene's revenues have an average growth rate of 16.9% with operating expenses growing at 17.2%. The company's current operating margins stand at 2.4%